News
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / Other news releases
Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® -
-
COMMUNIQUÉ DE PRESSE
Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l'Offre à 747,5 M$ (637,5 M€)
Abivax annonce exercice intégral option souscription ADS supplémentaires. Produit brut Offre à 747,5 M$. Société biotechnologie spécialisée en immunothérapie. Prix offre 64,00$ par ADS. Actions admises Nasdaq et Euronext. Document relatif déposé auprès de la SEC -
COMMUNIQUÉ DE PRESSE
Rational AG: Continuity on the Executive Board – Markus Paschmann appointed to the Executive Board for Sales and Marketing for a further three years.
Rational AG extends Markus Paschmann's contract on the Executive Board for Sales and Marketing for another three years, emphasizing continuity and growth -
COMMUNIQUÉ DE PRESSE
Coinsilium Group Limited: Result of Substantially Oversubscribed WRAP Retail Offer
Coinsilium Group Limited confirms result of substantially oversubscribed WRAP Retail Offer raising £500,000 with 4 times demand. New Ordinary Shares issued at 6p/share. Total voting rights to be 487,234,495 upon Admission -
-
COMMUNIQUÉ DE PRESSE
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
Abivax announces full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5M (€637.5M). Company to apply net proceeds to identified use of funds -
COMMUNIQUÉ DE PRESSE
Abivax annonce l’exercice intégral de l’option de souscription d’ADS supplémentaires des teneurs de livre associés, portant le produit brut de l'Offre à 747,5 M$ (637,5 M€)
Abivax a exercé intégralement l’option de souscription d’ADS supplémentaires, portant le produit brut de l'Offre à 747,5 M$ (637,5 M€), soutenant le développement de thérapies pour maladies inflammatoires -
COMMUNIQUÉ DE PRESSE
Steyr Motors also Expands in Maritime Applications – Supply Agreements Exceeding EUR 20 Million Signed
Steyr Motors AG signs EUR 20 million supply agreements for maritime applications, expanding internationally with partners in UK, Italy, France, and China. Diversification strategy boosts growth
